Literature DB >> 25352206

Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.

Xu Chen1, Daishan Jiang2, Jing Wang1, Xiaolan Chen1, Xiaolin Xu1, Peipei Xi2, Yaping Fan1, Xiaoyan Zhang1, Youfei Guan1.   

Abstract

Increasing evidence indicates that transforming growth factor-β1 (TGF-β1) is a pivotal mediator in the pathogenesis of renal fibrosis. Mesangial cells (MCs) are important for glomerular function under both physiological and pathological conditions. Studies have found that the expression level of prostaglandin E2 (PGE2) in MCs increases under high glucose conditions, that PGE2 affects the proliferation and hypertrophy of MCs mainly through the EP1 pathway, and that the proliferation of MCs and the accumulation of extracellular matrix are the main events leading to glomerular fibrosis. In this study, we investigated the effects and mechanisms of action of the EP1 receptor, which is induced by transforming growth factor (TGF)-β1, on the proliferation of mouse MCs, the accumulation of extracellular matrix and the expression of PGE2 synthase. Primary mouse glomerular MCs were isolated from EP1 receptor-deficient mice (EP1-/- mice, in which the EP1 receptor was knocked down) and wild-type (WT) mice (WT MCs). In our preliminary experiments, we found that cell proliferation, as well as the mRNA and protein expression of cyclin D1, proliferating cell nuclear antigen (PCNA), fibronectin (FN), collagen I (ColI), membrane-associated PGE2 synthase-1 (mPGES-1) and cyclooxygenase-2 (COX-2) in the WT MCs were significantly increased following treatment with 10 ng/ml TGF-β1 for 24 h. Compared with the WT MCs, following the knockdown of the EP1 gene, the TGF-β1-induced MC injury was markedly suppressed. The aforementioned changes were notably enhanced following treatment with the EP1 agonist, 17-phenyl trinor PGE2 ethyl amide. Additionally, TGF-β1 induced extracellular signal-regulated kinase (ERK) phosphorylation. We found that the TGF-β1-induced ERK phosphorylation was alleviated by EP1 knockdown and promoted by EP1 expression. These results suggest that the EP1 receptor plays a role in the proliferation of mouse MCs, in the accumulation of extracellular matrix and in the expression of mPGES-1 induced by TGF-β1. Its mechanisms of action are possibly related to the reinforcement of ERK phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25352206     DOI: 10.3892/ijmm.2014.1979

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

Review 1.  Make Precision Medicine Work for Chronic Kidney Disease.

Authors:  Ling Sun; Lu-Xi Zou; Mao-Jie Chen
Journal:  Med Princ Pract       Date:  2016-12-14       Impact factor: 1.927

2.  The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.

Authors:  Anna Theiler; Viktoria Konya; Lisa Pasterk; Jovana Maric; Thomas Bärnthaler; Ilse Lanz; Wolfgang Platzer; Rufina Schuligoi; Akos Heinemann
Journal:  Vascul Pharmacol       Date:  2016-09-21       Impact factor: 5.773

3.  EP1 receptor antagonism mitigates early and late stage renal fibrosis.

Authors:  Jean-Claude Kresse; Henricus A M Mutsaers; Michael Schou Jensen; Stine Julie Tingskov; Mia Gebauer Madsen; Lene N Nejsum; Helle Praetorius; Rikke Nørregaard
Journal:  Acta Physiol (Oxf)       Date:  2022-01-30       Impact factor: 7.523

4.  Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis.

Authors:  Xu Chen; Jun Yin; Yuyin Xu; Zhi Qiu; Jing Liu; Xiaolan Chen
Journal:  Mol Med Rep       Date:  2020-07-23       Impact factor: 2.952

Review 5.  The Roles of Various Prostaglandins in Fibrosis: A Review.

Authors:  Ke Li; Jing Zhao; Mingxuan Wang; Lingzhi Niu; Yuanping Wang; Yanxia Li; Yajuan Zheng
Journal:  Biomolecules       Date:  2021-05-24

6.  PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice.

Authors:  Jinying Wei; Xinna Deng; Yang Li; Runmei Li; Zhaohua Yang; Xiuyuan Li; Shan Song; Yonghong Shi; Huijun Duan; Haijiang Wu
Journal:  Oxid Med Cell Longev       Date:  2021-09-17       Impact factor: 6.543

7.  Prostaglandin E2 receptors as therapeutic targets in renal fibrosis.

Authors:  Henricus A M Mutsaers; Rikke Nørregaard
Journal:  Kidney Res Clin Pract       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.